Maharaj Nakorn Chiang Mai hospital Faculty of Medicine

Chiang Mai 50200

0 studies enrolling now · 3 studies all time

What they study most

Ischemic Stroke; Ischemic Attack, Transient, Mantle Cell Lymphoma, Pulmonary Arterial Hypertension

Studies at this site

• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension — Running, not enrolling
• Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma — Completed